Hide metadata

dc.date.accessioned2022-08-17T15:51:37Z
dc.date.available2022-08-17T15:51:37Z
dc.date.created2022-05-16T19:01:44Z
dc.date.issued2022
dc.identifier.citationRajthala, Saroj Parajuli, Himalaya Dongre, Harsh Nitin Ljøkjel, Borghild Hoven, Kristin Marie Kvalheim, Arild Lybak, Stein Neppelberg, Evelyn Sapkota, Dipak Johannessen, Anne Christine Costea, Daniela Elena . MicroRNA-138 abates fibroblast motility with effect on invasion of adjacent cancer cells. Frontiers in Oncology. 2022, 12:833582, 1-13
dc.identifier.urihttp://hdl.handle.net/10852/95037
dc.description.abstractBackground Recent studies have shown aberrant expression of micro-RNAs in cancer-associated fibroblasts (CAFs). This study aimed to investigate miR-138 dysregulation in CAFs in oral squamous cell carcinoma (OSCC) and its effects on their phenotype and invasion of adjacent OSCC cells. Methods Expression of miR-138 was first investigated in OSCC lesions ( n = 53) and OSCC-derived CAFs ( n = 15). MiR-138 mimics and inhibitors were used to functionally investigate the role of miR-138 on CAF phenotype and the resulting change in their ability to support OSCC invasion. Results Expression of miR-138 showed marked heterogeneity in both OSCC tissues and cultured fibroblasts. Ectopic miR-138 expression reduced fibroblasts’ motility and collagen contraction ability and suppressed invasion of suprajacent OSCC cells, while its inhibition resulted in the opposite outcome. Transcript and protein examination after modulation of miR-138 expression showed changes in CAF phenotype-specific molecules, focal adhesion kinase axis, and TGFβ1 signaling pathway. Conclusions Despite its heterogeneous expression, miR-138 in OSCC-derived CAFs exhibits a tumor-suppressive function.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleMicroRNA-138 abates fibroblast motility with effect on invasion of adjacent cancer cells
dc.title.alternativeENEngelskEnglishMicroRNA-138 abates fibroblast motility with effect on invasion of adjacent cancer cells
dc.typeJournal article
dc.creator.authorRajthala, Saroj
dc.creator.authorParajuli, Himalaya
dc.creator.authorDongre, Harsh Nitin
dc.creator.authorLjøkjel, Borghild
dc.creator.authorHoven, Kristin Marie
dc.creator.authorKvalheim, Arild
dc.creator.authorLybak, Stein
dc.creator.authorNeppelberg, Evelyn
dc.creator.authorSapkota, Dipak
dc.creator.authorJohannessen, Anne Christine
dc.creator.authorCostea, Daniela Elena
cristin.unitcode185,16,15,0
cristin.unitnameInstitutt for oral biologi
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2024979
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Frontiers in Oncology&rft.volume=12:833582&rft.spage=1&rft.date=2022
dc.identifier.jtitleFrontiers in Oncology
dc.identifier.volume12
dc.identifier.doihttps://doi.org/10.3389/fonc.2022.833582
dc.identifier.urnURN:NBN:no-97546
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2234-943X
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/95037/1/fonc-12-833582.pdf
dc.type.versionPublishedVersion
cristin.articleid833582


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International